This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Al-Ani B.: Simvastatin inhibits neutrophil degranulation induced by anti-neutrophil cytoplasm auto-antibodies and N-formyl-methionine-leucine-phenylalanine (fMLP) peptide. Saudi Med J 2013, 34, 477–483.Al-AniB.Simvastatin inhibits neutrophil degranulation induced by anti-neutrophil cytoplasm auto-antibodies and N-formyl-methionine-leucine-phenylalanine (fMLP) peptideSaudi Med J201334477–483Search in Google Scholar
Al-Rasheed N.M., Al-Rasheed N.M., Hasan I.H., Al-Ajmi H.N., Mohamad R.A., Mahmoud A.M.: Simvastatin ameliorates diabetic cardiomyopathy by attenuating oxidative stress and inflammation in rats. Oxid Med Cell Longev 2017, 10.1155/2017/1092015Al-RasheedN.M.Al-RasheedN.M.HasanI.H.Al-AjmiH.N.MohamadR.A.MahmoudA.M.Simvastatin ameliorates diabetic cardiomyopathy by attenuating oxidative stress and inflammation in ratsOxid Med Cell Longev201710.1155/2017/1092015Open DOISearch in Google Scholar
Antons K.A., Williams C.D., Baker S.K., Phillips P.S.: Clinical perspectives of statin-induced rhabdomyolysis. Am J Med 2006, 119, 400–409.AntonsK.A.WilliamsC.D.BakerS.K.PhillipsP.S.Clinical perspectives of statin-induced rhabdomyolysisAm J Med2006119400–40910.1016/j.amjmed.2006.02.007Search in Google Scholar
Black A.E., Hayes R.N., Roth B.D., Woo P., Woolf T.F.: Metabolism and excretion of atorvastatin in rats and dogs. Drug Metab Dispos 2000, 27, 916–992.BlackA.E.HayesR.N.RothB.D.WooP.WoolfT.F.Metabolism and excretion of atorvastatin in rats and dogsDrug Metab Dispos200027916–992Search in Google Scholar
Buhaescu I., Izzedine H.: Mevalonate pathway: a review of clinical and therapeutical implications. Clin Biochem 2007, 40, 575–584.BuhaescuI.IzzedineH.Mevalonate pathway: a review of clinical and therapeutical implicationsClin Biochem200740575–58410.1016/j.clinbiochem.2007.03.016Search in Google Scholar
Chang C.C., Chiu P.F., Chen H.L., Chang T.L., Chang Y.J., Huang C.H.: Simvastatin downregulates the expression of hepcidin and erythropoietin in HepG2 cells. Hemodial Int 2013, 17, 116–121.ChangC.C.ChiuP.F.ChenH.L.ChangT.L.ChangY.J.HuangC.H.Simvastatin downregulates the expression of hepcidin and erythropoietin in HepG2 cellsHemodial Int201317116–12110.1111/j.1542-4758.2012.00716.xSearch in Google Scholar
Chello M., Anselmi A., Spadaccio C., Patti G., Goffredo C., Di Sciascio G., Covino E.: Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery. Ann Thorac Surg 2007, 83, 1374–1380.ChelloM.AnselmiA.SpadaccioC.PattiG.GoffredoC.DiSciascio G.CovinoE.Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgeryAnn Thorac Surg2007831374–138010.1016/j.athoracsur.2006.10.065Search in Google Scholar
Chello M., Patti G., Candura D., Mastrobuoni S., Di Sciascio G., Agro F., Carassiti M., Covino E.: Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med 2006, 34, 660–667.ChelloM.PattiG.CanduraD.MastrobuoniS.DiSciascio G.AgroF.CarassitiM.CovinoE.Effects of atorvastatin on systemic inflammatory response after coronary bypass surgeryCrit Care Med200634660–66710.1097/01.CCM.0000201407.89977.EASearch in Google Scholar
Edwards C.J., Hart D.J., Spector T.D.: Oral statin and increased bone mineral density in postmenopausal women. Lancet, 2000, 355, 2218–2219.EdwardsC.J.HartD.J.SpectorT.D.Oral statin and increased bone mineral density in postmenopausal womenLancet20003552218–221910.1016/S0140-6736(00)02408-9Search in Google Scholar
Endres M.: Statins: potential new indications in inflammatory conditions. Atheroscler Suppl 2006, 7, 31–35.EndresM.Statins: potential new indications in inflammatory conditionsAtheroscler Suppl2006731–3510.1016/j.atherosclerosissup.2006.01.00516503422Search in Google Scholar
Fan J., Rone M.B., Papadopoulos V.: Translocator protein 2 is involved in cholesterol redistribution during erythropoiesis J Biol Chem 2009, 284, 30484–30497.FanJ.RoneM.B.PapadopoulosV.Translocator protein 2 is involved in cholesterol redistribution during erythropoiesis J Biol Chem200928430484–3049710.1074/jbc.M109.029876278160319729679Search in Google Scholar
Fathi H.A., Allam A., Elsabahy M., Fetih G., El-Badry M.: Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatin. Colloids Surf B Biointerfaces 2017, 28, 236–245.FathiH.A.AllamA.ElsabahyM.FetihG.El-BadryM.Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatinColloids Surf B Biointerfaces201728236–24510.1016/j.colsurfb.2017.11.06429197789Search in Google Scholar
Glińska K., Nicpoń J., Pawlas M.: Mechanism of action statins and possibilities of their application in dog therapy. Med Weter 2006, 62, 254–256.GlińskaK.NicpońJ.PawlasM.Mechanism of action statins and possibilities of their application in dog therapyMed Weter200662254–256Search in Google Scholar
Godfrey L.M., Erramouspe J., Cleveland K.W.: Teratogenic risk of statins in pregnancy. Ann Pharmacother 2012, 46, 1419–1424.GodfreyL.M.ErramouspeJ.ClevelandK.W.Teratogenic risk of statins in pregnancyAnn Pharmacother2012461419–142410.1345/aph.1R20223032657Search in Google Scholar
Huang X., Liang Y., Yang Y., Lu X.: Single-step production of the simvastatin precursor monacolin J by engineering of an industrial strain of Aspergillus terreus Metab Eng 2017, 42, 109–114.HuangX.LiangY.YangY.LuX.Single-step production of the simvastatin precursor monacolin J by engineering of an industrial strain of Aspergillus terreusMetab Eng201742109–11410.1016/j.ymben.2017.06.00528619444Search in Google Scholar
Ii M., Losordo D.W.: Statins and the endothelium. Vasc Pharmacol 2007, 46, 1–9.IiM.LosordoD.W.Statins and the endotheliumVasc Pharmacol2007461–910.1016/j.vph.2006.06.01216920035Search in Google Scholar
Matsuzawa Y., Kita T., Mabuchi H., Matsuzako M., Nakaya N., Oikawa S., Saito Y., Sasaki J., Shimamoto K., Itakura H.: The J-LIT group: sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effect in 51,321 Japanese hypercholesterolemic patients implication of the J-LIT study, a large scale nationwide cohort study. Circ J 2003, 67, 287–294.MatsuzawaY.KitaT.MabuchiH.MatsuzakoM.NakayaN.OikawaS.SaitoY.SasakiJ.ShimamotoK.ItakuraH.The J-LIT group: sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effect in 51,321 Japanese hypercholesterolemic patients implication of the J-LIT study, a large scale nationwide cohort studyCirc J200367287–29410.1253/circj.67.28712655157Search in Google Scholar
Mohammadian M., Sadeghipour H.R., Kashani I.R., Jahromi G.P., Omidi A., Nejad A.K., Golchoobian R., Boskabady M.H.: Evaluation of simvastatin and bone marrow-derived mesenchymal stem cell combination therapy on airway remodeling in a mouse asthma model. Lung 2016, 194, 777–785.MohammadianM.SadeghipourH.R.KashaniI.R.JahromiG.P.OmidiA.NejadA.K.GolchoobianR.BoskabadyM.H.Evaluation of simvastatin and bone marrow-derived mesenchymal stem cell combination therapy on airway remodeling in a mouse asthma modelLung2016194777–78510.1007/s00408-016-9884-127161569Search in Google Scholar
Namazi M.R., Handjani F., Sodaifi M.: The potential utility of statins as novel weapons against graft-versus-host disease. Med Hypotheses 2005, 65, 1203–1204.NamaziM.R.HandjaniF.SodaifiM.The potential utility of statins as novel weapons against graft-versus-host diseaseMed Hypotheses2005651203–120410.1016/j.mehy.2005.06.00916139438Search in Google Scholar
Newman A., Clutterbuck R.D., Powles R.L., Millar J.L.: Selective inhibition of primary acute myeloid leukaemia cell growth by lovastatin. Leukemia 1994, 8, 274–280.NewmanA.ClutterbuckR.D.PowlesR.L.MillarJ.L.Selective inhibition of primary acute myeloid leukaemia cell growth by lovastatinLeukemia19948274–280Search in Google Scholar
Nomura T.: Japanese clinical statistical data of patients with aplastic anemia. Nippon Rinsho 1992, 50, 735–746.NomuraT.Japanese clinical statistical data of patients with aplastic anemiaNippon Rinsho199250735–746Search in Google Scholar
Piorkowski M., Fisher S., Stellbaum C., Jaster M., Martus P., Morguet A.J., Schultheiss H.P., Rauch U.: Treatment with ezetimibe plus low-dose Atorvastatin compared with higher-dose Atorvastatin alone. J Am Coll Cardiol 2007, 48, 1035–1042.PiorkowskiM.FisherS.StellbaumC.JasterM.MartusP.MorguetA.J.SchultheissH.P.RauchU.Treatment with ezetimibe plus low-dose Atorvastatin compared with higher-dose Atorvastatin aloneJ Am Coll Cardiol2007481035–104210.1016/j.jacc.2006.10.06417349882Search in Google Scholar
Pucetti L., Bruni F., Bova G., Cercignani M., Pompella A., Auteri A., Pasqui A.I.: Role of platelets in tissue factor expression by monocytes in normal and hypercholesterolaemia subjects. In vivo effect of cerivastatin. Int J Clin Lab Res 2000, 30, 147–156.PucettiL.BruniF.BovaG.CercignaniM.PompellaA.AuteriA.PasquiA.I.Role of platelets in tissue factor expression by monocytes in normal and hypercholesterolaemia subjectsIn vivo effect of cerivastatin. Int J Clin Lab Res200030147–15610.1007/s00599007001411196073Search in Google Scholar
Shahbazian H., Atrian A., Yazdanpanah L., Lashkarara G.R., Zafar Mohtashami A.: Anti-inflammatory effect of simvastatin in hemodialysis patients. Jundishapur J Nat Pharm Prod 2015, 10, el17962.ShahbazianH.AtrianA.YazdanpanahL.LashkararaG.R.ZafarMohtashami A.Anti-inflammatory effect of simvastatin in hemodialysis patientsJundishapur J Nat Pharm Prod201510el1796210.17795/jjnpp-17962438631925866715Search in Google Scholar
Shimamura M., Urabe A., Takaku F., Mizuno M.: Effects of dolichol and dolichyl phosphate on in vitro differentiation of hematopoietic progenitors. Int J Cell Cloning 1985, 3, 313–319.ShimamuraM.UrabeA.TakakuF.MizunoM.Effects of dolichol and dolichyl phosphate on in vitro differentiation of hematopoietic progenitorsInt J Cell Cloning19853313–31910.1002/stem.55300305044045257Search in Google Scholar
Slawinska A., Kandefer-Szerszen M.: The anticancer properties of statins. Postępy Hig Med Dosw 2008, 62, 393–404.SlawinskaA.Kandefer-SzerszenM.The anticancer properties of statinsPostępy Hig Med Dosw200862393–404Search in Google Scholar
Snarska A., Gonkowski S., Rytel L., Pomianowski A., Babińska I., Otrocka-Domagała I., Żarczyńska K., Wysocka D., Sobiech P.: Influence of simvastatin on red blood cell line in porcine bone marrow. Pol J Vet Sci 2017, 4, 811–814.SnarskaA.GonkowskiS.RytelL.PomianowskiA.BabińskaI.Otrocka-DomagałaI.ŻarczyńskaK.WysockaD.SobiechP.Influence of simvastatin on red blood cell line in porcine bone marrowPol J Vet Sci20174811–814Search in Google Scholar
Sukpat S., Isrrasena N., Patumraj S.: Pleiotropic effects of simvastatin on wound healing in diabetic mice. J Med Assoc Thai 2016, 99, 213–219.SukpatS.IsrrasenaN.PatumrajS.Pleiotropic effects of simvastatin on wound healing in diabetic miceJ Med Assoc Thai201699213–219Search in Google Scholar
Tun T., Kang Y.S.: Effects of simvastatin on CAT-1 mediated arginine transport and NO level under high glucose conditions in conditionally immortalized rat inner blood-retinal barrier cell lined (TR-iBRB). Microvasc Res 2017, 111, 60–66.TunT.KangY.S.Effects of simvastatin on CAT-1 mediated arginine transport and NO level under high glucose conditions in conditionally immortalized rat inner blood-retinal barrier cell lined (TR-iBRB)Microvasc Res201711160–6610.1016/j.mvr.2017.01.00228089735Search in Google Scholar
Vilimanovich U., Bosnjak M., Bogdanovic A., Markovic I., Isakovic A., Kravic-Stevovic T., Mircic A., Trajkovic V., Bumbasirevic V.: Statin-mediated inhibition of cholesterol synthesis induces cytoprotective autophagy in human leukemic cells. Eur J Pharmacol 2015, 15, 415–428.VilimanovichU.BosnjakM.BogdanovicA.MarkovicI.IsakovicA.Kravic-StevovicT.MircicA.TrajkovicV.BumbasirevicV.Statin-mediated inhibition of cholesterol synthesis induces cytoprotective autophagy in human leukemic cellsEur J Pharmacol201515415–42810.1016/j.ejphar.2015.09.00426358205Search in Google Scholar
Wong M.J., Kantores C., Ivanovska J., Jain A., Jankov R.P.: Simvastatin prevents and reverses chronic pulmonary hypertension in newborn rats via pleiotropic inhibition of RhoA signaling. Am J Physiol Lung Cell Mol Physiol 2016, 311, 985–999.WongM.J.KantoresC.IvanovskaJ.JainA.JankovR.P.Simvastatin prevents and reverses chronic pulmonary hypertension in newborn rats via pleiotropic inhibition of RhoA signalingAm J Physiol Lung Cell Mol Physiol2016311985–99910.1152/ajplung.00345.201627694473Search in Google Scholar
